Intensity Therapeutics, Inc. (INTS)
USD 1.91
(-4.5%)
USD 1.91
(-4.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -7.2 Million | -5.47 Million | -6.82 Million | -5.37 Million | -4.41 Million |
| Net Income | -10.53 Million | -7.58 Million | -7.89 Million | -6.03 Million | -5.37 Million |
| Depreciation & Amortization | 147 Thousand | 179.03 Thousand | - | - | - |
| Deferred income taxes | -1.63 Million | -179.03 Thousand | - | - | - |
| Stock-based compensation | 1.39 Million | 1.16 Million | 719.82 Thousand | 555.48 Thousand | 561.37 Thousand |
| Change in working capital | -633 Thousand | 756.68 Thousand | 176.8 Thousand | -12.03 Thousand | 306.9 Thousand |
| Other non-cash items | 4.05 Million | 179.03 Thousand | 172.11 Thousand | 116.83 Thousand | 95.2 Thousand |
| Investing Cash Flow | -6.02 Million | - | - | 4.56 Million | 1.69 Million |
| Investments in PPE | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -15.05 Million | - | - | -10.89 Million | -7.07 Million |
| Sales/Maturities of investments | 9.03 Million | - | - | 15.46 Million | 8.76 Million |
| Other Investing Activities | 9.03 Million | - | - | - | - |
| Financing Cash Flow | 20.47 Million | 2.25 Million | 2.05 Million | 6.29 Million | 3.85 Million |
| Debt repayment | -230 Thousand | -2.25 Million | -2 Million | - | - |
| Dividends payments | -1.32 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 20.24 Million | - | - | 6.26 Million | 3.85 Million |
| Other Financing Activities | -2.23 Million | 4.5 Million | 4.05 Million | 25 Thousand | - |
| Accounts receivables | - | - | 16.76 Thousand | - | - |
| Accounts payables | 1.63 Million | 430.66 Thousand | -50.19 Thousand | -171.25 Thousand | 202.55 Thousand |
| Inventory | - | - | -16.76 Thousand | - | - |
| Other working capital | -2.26 Million | 326.02 Thousand | 227 Thousand | 159.22 Thousand | 104.35 Thousand |
| Cash at beginning of period | 1.31 Million | 4.53 Million | 9.31 Million | 3.82 Million | 2.68 Million |
| Cash at end of period | 8.55 Million | 1.31 Million | 4.53 Million | 9.31 Million | 3.82 Million |
| Capital Expenditure | - | - | - | - | - |
| Effect of forex changes on cash | 123.00 | - | - | - | - |
| Net cash flow / Change in cash | 7.24 Million | -3.22 Million | -4.77 Million | 5.48 Million | 1.13 Million |
| Free Cash Flow | -7.2 Million | -5.47 Million | -6.82 Million | -5.37 Million | -4.41 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.97 Million | -4.6 Million | -3.17 Million | -10.53 Million | -2.32 Million | -3.7 Million |
| Depreciation & Amortization | 6000.00 | 6000.00 | 5892.00 | 147 Thousand | 2019.00 | 38.61 Thousand |
| Deferred income taxes | - | - | 1.44 Million | -1.63 Million | -2019.00 | - |
| Stock-based compensation | 591 Thousand | 1.15 Million | 422.57 Thousand | 1.39 Million | 351.16 Thousand | 312.25 Thousand |
| Change in working capital | 160 Thousand | -924 Thousand | 1.79 Million | -633 Thousand | -3.03 Million | 703.31 Thousand |
| Other non-cash items | -40 Thousand | 2.61 Million | -1.44 Million | 4.05 Million | -108.91 Thousand | 2.4 Million |
| Investing Cash Flow | -6000.00 | 3.26 Million | 2.82 Million | -6.02 Million | -8.84 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -3.05 Million | - | -6.2 Million | -15.05 Million | -8.84 Million | - |
| Sales/Maturities of investments | 3.05 Million | 3.26 Million | 9.03 Million | 9.03 Million | - | - |
| Other Investing Activities | -3.05 Million | 3.26 Million | 9.03 Million | 9.03 Million | - | - |
| Financing Cash Flow | 3000.00 | 8000.00 | -12.16 Thousand | 20.47 Million | 20.52 Million | -241.83 Thousand |
| Debt repayment | - | - | -12.55 Thousand | -230 Thousand | -448.00 | -37.55 Thousand |
| Dividends payments | - | - | -1.32 Million | -1.32 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3000.00 | 8000.00 | 348.00 | 20.24 Million | 20.52 Million | -279.33 Thousand |
| Other Financing Activities | 3000.00 | 8000.00 | 44.00 | -2.23 Million | -1.95 Million | -44.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 643 Thousand | -1.44 Million | 1.87 Million | 1.63 Million | -1.22 Million | 682.37 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -483 Thousand | 523 Thousand | -80.32 Thousand | -2.26 Million | -1.8 Million | 20.94 Thousand |
| Cash at beginning of period | 7.45 Million | 8.55 Million | 6.69 Million | 1.31 Million | 135.76 Thousand | 616.5 Thousand |
| Cash at end of period | 3.24 Million | 7.45 Million | 8.55 Million | 8.55 Million | 6.69 Million | 135.76 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 123.00 | 123.00 | -6.37 Million | - |
| Net cash flow / Change in cash | -4.21 Million | -1.09 Million | 1.86 Million | 7.24 Million | 6.55 Million | -480.74 Thousand |
| Free Cash Flow | -4.21 Million | -4.36 Million | -947.16 Thousand | -7.2 Million | -5.11 Million | -238.91 Thousand |
LUXFF
MASFIN
600375
0QKP
BTC
6558